Bellevue Life Sciences-WRNTOSRHWPreferred / convertible

13F holders, Q3 2025 (September 30)
20holders −1
1new positions
2sold out
1famous investor
$0.08avg. 13F price*

At the end of Q3 2025, 20 institutions reported holding Bellevue Life Sciences-WRNT (OSRHW) in their 13F filings, down 1 from Q2 2025. 1 opened new positions and 2 sold out. The largest holders were Boothbay Fund Management, LLC ($166K), Toronto Dominion Bank ($20K) and Polar Asset Management Partners Inc. ($14K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Bellevue Life Sciences-WRNT
Filed as
OSR HLDGS INC (Q3 2025)
CUSIP
68840D110
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2025: 20Q1 2025Q2 2025: 21Q2 2025Q3 2025: 20Q3 2025Q4 2025: 17Q4 2025Q1 2026: 16Q1 2026Q2 2026: 19Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$69
Exits2$3K

All 13F filers, Q2 2025 → Q3 2025: 9,468 shares bought and 53,808 shares sold, net −44,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 20 holders
Boothbay Fund Management, LLC — No change 311,040 $166K
Toronto Dominion Bank — No change 489,472 $20K
Polar Asset Management Partners Inc. — No change 360,000 $14K
Atw Spac Management LLC — No change 311,040 $13K
Periscope Capital Inc. — No change 299,900 $12K
Clear Street Group Inc. — — 292,283 $12K
LMR Partners LLP — No change 253,001 $10K
Rivernorth Capital Management, LLC — No change 250,000 $10K
Saba Capital Management, L.P. — No change 250,000 $10K
D. E. Shaw & Co. — No change 150,000 $6K
Wolverine Asset Management LLC — Reduce -3.8% 111,980 $5K
Centiva Capital, LP — No change 100,000 $4K
Mint Tower Capital Management B.V. — No change 75,000 $3K
Aristeia Capital, L.L.C. — No change 73,341 $3K
Susquehanna International Group, LLP — Add +19.3% 47,962 $2K
Gabelli Funds LLC — No change 27,050 $1K
Flow Traders U.S. LLC — Add +0.1% 23,447 $1K
SkyView Investment Advisors, LLC — No change 30,000 $1K
GABELLI & Co INVESTMENT ADVISERS, INC. — No change 20,800 $847
UBS Group AG — New 1,676 $69

"% of holder's portfolio" is OSRHW's weight in each manager's 13F, not the share of Bellevue Life Sciences-WRNT the manager owns.